- Market cap
- Revenue
- Net income
- Cash on hand
- Gross margin
- Net margin
- EPS
- P/E ratio
The company was founded as ImmuDyne, Inc. in 1994 and completed its initial public offering in 2001. In 2018, it rebranded as Conversion Labs, Inc. with Justin Schreiber named chief executive officer. The company changed its name to LifeMD in 2020 and started using the ticker name LFMD.
In the first quarter of 2025, LifeMD reported that total revenues increased 49% YoY to $65.7 million.